Penn Medicine Cellicon Valley '23: The Future of Cell and Gene Therapies

 

Penn Medicine Cellicon Valley '23: The Future of Cell and Gene Therapies
L

Highly Proliferating and Exhausted T-Cells in Leukapheresis Associate with Lack of Response to Anti-CD19 CAR T-Cells in R/R B-Cell NHL

By Penn Medicine Cellicon Valley '23: The Future of Cell and Gene Therapies FEATURING Luca Paruzzo
By Penn Medicine Cellicon Valley '23: The Future of Cell and Gene Therapies FEATURING Luca Paruzzo
32 views
August 10, 2023
0 Comments
Login to view comments. Click here to Login

Featured Video

24:35
Indy Hematology Review

Current Approaches in the Treatment of Myeloproliferative Neoplasms

Feat. A. Tefferi

Featured Video

24:44
Indy Hematology Review

State of the Art in 2024: Emerging Therapies in Hematologic Malignan…

Feat. R. Birhiray
Plenary Sessions
20:03
Penn Medicine Cellicon Valley '23: The Future of Cell and Gene Therapies

Developing Novel Classes of Therapeutics: Walking a Tightrope Withou…

Feat. K. High
19:17
Penn Medicine Cellicon Valley '23: The Future of Cell and Gene Therapies

Gene Therapy: A Case Study for Disruptive Technology

Feat. J. Wilson
27:38
Penn Medicine Cellicon Valley '23: The Future of Cell and Gene Therapies

Potency Enhancements to Improve CAR Efficacy Against Solid Cancers

Feat. C. Mackall
24:29
Penn Medicine Cellicon Valley '23: The Future of Cell and Gene Therapies

Hemophilia A & B: Model Monogenic Disorders for Gene Therapy

Feat. L. George
17:38
Penn Medicine Cellicon Valley '23: The Future of Cell and Gene Therapies

Curative Potential of CAR T-Cell Therapy for ALL

Feat. S. Grupp
16:20
Penn Medicine Cellicon Valley '23: The Future of Cell and Gene Therapies

Long-Term Data in Lymphoma: Can CAR T-Cells Cure Patients?

Feat. F. Locke
20:38
Penn Medicine Cellicon Valley '23: The Future of Cell and Gene Therapies

Risk of Malignancies After Curative Therapies for Hemoglobinopathies

Feat. J. Tisdale
24:51
Penn Medicine Cellicon Valley '23: The Future of Cell and Gene Therapies

Therapeutic Induction of Fetal Hemoglobin for Treating Sickle Cell D…

Feat. M. Weiss
18:32
Penn Medicine Cellicon Valley '23: The Future of Cell and Gene Therapies

Genome Editing of HSCs: Sickle Cell Disease, HIV, and Technology Adv…

Feat. M. Porteus
19:04
Penn Medicine Cellicon Valley '23: The Future of Cell and Gene Therapies

Updates on CAR T-Cell Therapy for T-Cell ALL

Feat. D. Teachey
17:20
Penn Medicine Cellicon Valley '23: The Future of Cell and Gene Therapies

Global Expansion of CAR T-Cell Therapy: India

Feat. A. Anand
16:53
Penn Medicine Cellicon Valley '23: The Future of Cell and Gene Therapies

Global Expansion of CAR T-Cell Therapy: Middle East

Feat. S. Hashmi
12:46
Penn Medicine Cellicon Valley '23: The Future of Cell and Gene Therapies

Global Expansion of CAR T-Cell Therapy: Australia and New Zealand

Feat. S. Harrison
27:29
Penn Medicine Cellicon Valley '23: The Future of Cell and Gene Therapies

Implementing CAR T-Cell Therapy in Costa Rica: Science Diplomacy, Pe…

Feat. R. Macaya Hayes
21:12
Penn Medicine Cellicon Valley '23: The Future of Cell and Gene Therapies

Scaling the Clinical Promise of CRISPR to the Challenge of N=1 Inbor…

Feat. F. Urnov
19:11
Penn Medicine Cellicon Valley '23: The Future of Cell and Gene Therapies

Programming Cellular Machines to Sense and Treat Disease

Feat. W. Lim
25:55
Penn Medicine Cellicon Valley '23: The Future of Cell and Gene Therapies

Precision Therapeutic Gene Correction in Cells, Animals, and Patients

Feat. D. Liu
26:09
Penn Medicine Cellicon Valley '23: The Future of Cell and Gene Therapies

Nucleoside-Modified mRNA-LNP Therapies

Feat. D. Weissman
40:35
Penn Medicine Cellicon Valley '23: The Future of Cell and Gene Therapies

Crossing Borders: Cell and Gene Therapy Outside the Boundaries

Feat. S. Mukherjee
32:52
Penn Medicine Cellicon Valley '23: The Future of Cell and Gene Therapies

The Improbable History of CAR T-Cells

Feat. C. June
16:47
Penn Medicine Cellicon Valley '23: The Future of Cell and Gene Therapies

CAR T-Cell Therapy for Advanced Prostate Cancer: Clinical Trials and…

Feat. V. Narayan
05:14
Penn Medicine Cellicon Valley '23: The Future of Cell and Gene Therapies

Highly Proliferating and Exhausted T-Cells in Leukapheresis Associat…

Feat. L. Paruzzo
20:50
Penn Medicine Cellicon Valley '23: The Future of Cell and Gene Therapies

The Multiple Roadblocks to Access for CAR-T in MM: Optimizing Road C…

Feat. K. Patel
27:25
Penn Medicine Cellicon Valley '23: The Future of Cell and Gene Therapies

Three CAR-T Studies in 2L DLBCL: What Happened and Why in ZUMA-7, BE…

Feat. S. Schuster